Oct 12
|
The Ultimate Biotech Stock to Buy With $100 Right Now
|
Oct 10
|
Here's Why Viking Therapeutics, Inc. (VKTX) Fell More Than Broader Market
|
Oct 10
|
Viking reports data from X-linked adrenoleukodystrophy trial
|
Oct 9
|
Viking Therapeutics Reveals Encouraging Data From Genetic Disorder Drug Study, Analyst Says Focus On Orphan Disease Broadens Viking's Potential Revenue Streams
|
Oct 9
|
Viking Therapeutics Announces Results from Phase 1b Clinical Trial of VK0214 in Patients with X-ALD
|
Oct 7
|
Viking Therapeutics, Inc. (VKTX): A Hot Stock to Buy Now
|
Oct 7
|
2 Soaring Stocks That Could Climb Another 112% and 120%, According to Wall Street Analysts
|
Oct 4
|
Viking Therapeutics, Inc. (VKTX) Rises Higher Than Market: Key Facts
|
Oct 4
|
As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer
|
Oct 3
|
Why Viking Therapeutics, Inc. (VKTX) Dipped More Than Broader Market Today
|
Oct 2
|
Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now
|
Sep 30
|
Why Viking Therapeutics Stock Topped the Market Today
|
Sep 29
|
Is Viking Therapeutics, Inc. (VKTX) the Best Performing Long Term Stock in 2024?
|
Sep 28
|
Better Rising Biotech: Viking Therapeutics vs. Summit Therapeutics
|
Sep 27
|
Viking Therapeutics, Inc. (VKTX) Falls More Steeply Than Broader Market: What Investors Need to Know
|
Sep 5
|
Prediction: This Biotech Stock Will Outperform Nvidia in the Second Half of the Year
|
Sep 4
|
Viking Therapeutics, Inc. (VKTX) Sees a More Significant Dip Than Broader Market: Some Facts to Know
|
Sep 4
|
Several Factors Negatively Impacted Viking Therapeutics (VKTX) in Q2
|
Sep 3
|
The Best Biotech Stock to Invest $1,000 in Right Now
|
Sep 3
|
Viking Surges 342% in the Past Year: How Should You Play the Stock?
|